Evaluation of efficacy and safety of pegfilgrastim when given less than two weeks from dose-dense chemotherapy regimens.

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

The study findings suggest safety and efficacy when chemotherapy is administered 12-14 days from pegfilgrastim.

Keyphrases